Skip to search formSkip to main contentSkip to account menu

Orally Disintegrating Tablet Dosage Form

Known as: Orally Disintegrating Tablet, Tablet, Orally Disintegrating, orally Dis Tab 
A tablet which disintegrates and dissolves quickly (usually within a matter of seconds) in the mouth. Additional water to complete dissolution is not… 
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Pharmaceutical Dosage Form TerminologyClinical Data Interchange Standards Consortium TerminologyStructured Product Labeling Pharmaceutical Dosage Form Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Orally disintegrating tablet of novel salt of antiepileptic drug: formulation strategy and evaluation.
2011
2011
Sublingual fentanyl orally disintegrating tablet in daily practice: efficacy, safety and tolerability in patients with breakthrough cancer pain
Abstract Background and objectives: Breakthrough cancer pain (BTcP) affects more than half of patients with cancer pain and has… 
2011
2011
Formulation study for orally disintegrating tablet using partly pregelatinized starch binder.
In this study, we aimed to design orally disintegrating tablets by employing a formulation design approach that enables the… 
2006
2006
Initial Treatment of Severe Acute Psychosis with Fast Orally Disintegrating Risperidone Tablets
Introduction: Methods: Results: Conclusion: 
Review
2006
Review
2006
Selegiline orally disintegrating tablet in the treatment of Parkinsons disease
Mono- and adjunctive therapy with the oral monoamine oxidase B inhibitor selegiline has been used to treat motor complications… 
2004
2004
A novel option in proton pump inhibitor dosing: lansoprazole orally disintegrating tablet dispersed in water and administered via nasogastric tube
Background : Lansoprazole orally disintegrating tablet, which rapidly disintegrates on the tongue or in water, provides a dosing… 
Review
2003
Review
2003
Compliance: the impact of adverse events and tolerability on the physician’s treatment decisions
2003
2003
Real‐World Experiences in Migraine Therapy With Rizatriptan
Objective.—To evaluate the effectiveness of rizatriptan for acute migraine treatment and patient satisfaction with the drug in… 
Review
2002
Review
2002
Advances in Atypical Antipsychotics for the Treatment of Schizophrenia
Innovation in atypical antipsychotic agents continues with new preparations of available drugs as well as novel agents. In this… 
1990
1990
Ergebnisse der Radiojodtherapie der manifesten Hyperthyreose und der autonomen Struma mit Euthyreose
In 200 patients follow-up examinations were performed up to one year after radioiodine therapy (RITh) with individual dose… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)